Literature DB >> 15931160

Sensitization to brain antigens after stroke is augmented by lipopolysaccharide.

Kyra J Becker1, Darin L Kindrick, Mark P Lester, Connor Shea, Zu-Cheng Ye.   

Abstract

After stroke, the blood-brain barrier is transiently disrupted, allowing leukocytes to enter the brain and brain antigens to enter the peripheral circulation. This encounter of normally sequestered brain antigens by the systemic immune system could therefore present an opportunity for an autoimmune response to brain to occur after stroke. In this study, we assessed the immune response to myelin basic protein (MBP) in animals subjected to middle cerebral artery occlusion (MCAO). Some animals received an intraperitoneal injection of lipopolysaccharide (LPS; 1 mg/kg) at reperfusion to stimulate a systemic inflammatory response. At 1 month after MCAO, animals exposed to LPS were more likely to be sensitized to MBP (66.7% versus 22.2%; P=0.007) and had more profound and persistent neurologic deficits than non-LPS-treated animals. Exposure to LPS was associated with increased expression of the costimulatory molecule B7.1 early after stroke onset (P=0.009) and increased brain atrophy 1 month after MCAO (P=0.03). These data suggest that animals subjected to a systemic inflammatory insult at the time of stroke are predisposed to develop an autoimmune response to brain, and that this response is associated with worse outcome. These data may partially explain why patients who become infected after stroke experience increased morbidity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931160      PMCID: PMC2865130          DOI: 10.1038/sj.jcbfm.9600160

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  43 in total

1.  Short-lived immunization site inflammation in self-limited active experimental allergic encephalomyelitis.

Authors:  F Di Rosa; B Serafini; P Scognamiglio; A Di Virgilio; L Finocchi; F Aloisi; V Barnaba
Journal:  Int Immunol       Date:  2000-05       Impact factor: 4.823

2.  Antibodies to brain antigens following stroke.

Authors:  N M Bornstein; B Aronovich; A D Korczyn; S Shavit; D M Michaelson; J Chapman
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 3.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

4.  Behavioral aspects of experimental autoimmune encephalomyelitis.

Authors:  Y Pollak; H Ovadia; I Goshen; R Gurevich; K Monsa; R Avitsur; R Yirmiya
Journal:  J Neuroimmunol       Date:  2000-04-03       Impact factor: 3.478

5.  Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

Authors:  H L Weiner
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

6.  Presence of B7--2 (CD86) and lack of B7--1 (CD(80) on myelin phagocytosing MHC-II-positive rat microglia is associated with nondestructive immunity in vivo.

Authors:  I Bechmann; S Peter; M Beyer; U Gimsa; R Nitsch
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

7.  Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis.

Authors:  O S Targoni; J Baus; H H Hofstetter; M D Hesse; A Y Karulin; B O Boehm; T G Forsthuber; P V Lehmann
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

8.  Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein.

Authors:  M Herrmann; P Vos; M T Wunderlich; C H de Bruijn; K J Lamers
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

9.  Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial.

Authors: 
Journal:  Neurology       Date:  2001-10-23       Impact factor: 9.910

10.  Antigen-presenting cell activation: a link between infection and autoimmunity?

Authors:  S Kissler; S M Anderton; D C Wraith
Journal:  J Autoimmun       Date:  2001-05       Impact factor: 7.094

View more
  58 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

Review 2.  Strain-Related Differences in the Immune Response: Relevance to Human Stroke.

Authors:  Kyra J Becker
Journal:  Transl Stroke Res       Date:  2016-02-10       Impact factor: 6.829

3.  Splenectomy Does Not Improve Long-Term Outcome After Stroke.

Authors:  Dannielle Zierath; Angela Shen; Astiana Stults; Theresa Olmstead; Kyra J Becker
Journal:  Stroke       Date:  2017-01-13       Impact factor: 7.914

Review 4.  CNS immune privilege: hiding in plain sight.

Authors:  Monica J Carson; Jonathan M Doose; Benoit Melchior; Christoph D Schmid; Corinne C Ploix
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

5.  Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Authors:  John Hallenbeck; Gregory Del Zoppo; Tom Jacobs; Antoine Hakim; Stephen Goldman; Ursula Utz; Ahmed Hasan
Journal:  Stroke       Date:  2006-11-02       Impact factor: 7.914

Review 6.  Modulation of the postischemic immune response to improve stroke outcome.

Authors:  Kyra J Becker
Journal:  Stroke       Date:  2010-10       Impact factor: 7.914

7.  Lipopolysaccharide is a frequent and significant contaminant in microglia-activating factors.

Authors:  Jonathan R Weinstein; Sarah Swarts; Caroline Bishop; Uwe-Karsten Hanisch; Thomas Möller
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

Review 8.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

9.  Autoimmune responses to brain following stroke.

Authors:  Kyra Becker
Journal:  Transl Stroke Res       Date:  2012-04-05       Impact factor: 6.829

10.  Preoperative mucosal tolerance to brain antigens and a neuroprotective immune response following surgical brain injury.

Authors:  Robert E Ayer; Nazanin Jafarian; Wanqiu Chen; Richard L Applegate; Austin R T Colohan; John H Zhang
Journal:  J Neurosurg       Date:  2011-10-21       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.